The intranephronal distribution pattern of the activity of succinate dehydrogenase, a marker enzyme of mitochondrial inner membranes, was examined by histochemical investigation in the kidneys of 27 male Sprague-Dawley rats. The animals received cyclosporine A per os (15 30 or 50 mg/kg day) for 12 or 24 days. Six animals of the latter group remained untreated for a further 24 days. Five rats treated orally with 30 mg/kg day olive oil served as controls. The kidneys of 2 normal male Sprague-Dawley rats were examined for comparison. Cyclosporine A reversibly induced a characteristic pattern of nephron segments with various degrees of reduced succinate dehydrogenase activity: in the proximal and distal tubules of subcapsular areas of the cortical labyrinth, of the medullary rays, and of the outer stripe of the outer medulla. The remaining areas contained tubules with normal succinate dehydrogenase activity, as confirmed by microphotometrical measurement. The number of these tubules appeared to be decreased under higher doses of cyclosporine A, irrespective of the duration of treatment. The finding of heterogeneous affection of tubular mitochondrial cristae membranes reflects direct tubulotoxicity of cyclosporine A.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.